Engagement of sialylated glycans with Siglec receptors on myeloid suppressor cells inhibit anti-cancer immunity via CCL2 https://www.biorxiv.org/content/10.1101/2023.06.29.547025v1?med=mas
Engagement of sialylated glycans with Siglec receptors on myeloid suppressor cells inhibit anti-cancer immunity via CCL2 https://www.biorxiv.org/content/10.1101/2023.06.29.547025v1?med=mas